Collaborators

Impacta Peru: Javier Lama, MD, MPH, and Jorge Sanchez, MD, MPH

Impacta Peru: Javier Lama, MD, MPH, and Jorge Sanchez, MD, MPH

Impacta Peru is a non-profit organization dedicated to research in the fields of health and human behavior, consisting of multidisciplinary teams engaged in promoting the welfare of individuals and society.
Learn More


Epicentro

Epicentro

Epicentro is a non-profit organization dedicated to providing health services and community development to the LGTBI and general populations and advancing clinical research. The organization also implements programs for the prevention, diagnosis, and treatment of sexually transmitted infections and HIV-AIDS.
Learn More 


Via Libre

Via Libre

Via Libre works in favor of universal access to comprehensive health, with emphasis on sexual and reproductive health, and HIV, and to generate evidence from programs, services and research.
Learn More


Ying Chen Group

Ying Chen Group

The Ying Chen Group at the Fred Hutchinson Cancer Research Center conducts quantitative scientific research that employs biostatistics, bioinformatics, epidemiology, and mathematical modeling to better answer questions on human infectious disease processes and prevention.
Learn More


Yamile Molina, PhD, MPH, MS

Yamile Molina, PhD, MPH, MS

Yamile Molina, PhD, MPH, MS, is a faculty affiliate of the Center for Research on Women and Gender at the University of Illinois at Chicago. Her interests center on characterizing individual and community strengths that promote well-being and optimal healthcare utilization among marginalized and resilient groups, including people of color, LGBTQ-identified people and people living with chronic conditions.
Learn More


Nicolas Chomont, PhD

Nicolas Chomont, PhD

Nicolas Chomont, PhD, is an associate research professor in the Department of Microbiology, Infectiology and Immunology at the Université de Montréal. His research aims to dissect the molecular and immunological mechanisms involved in HIV viral latency, and develop new therapeutic strategies aimed at elimination of HIV reservoirs.
Learn More


Lisa Frenkel, MD, PhD

Lisa Frenkel, MD, PhD

Lisa Frenkel, MD, PhD, is a professor of pediatrics/infectious diseases and laboratory medicine, and adjunct professor in global health, at the University of Washington. Her work focuses on the prevention of HIV-1 infection in infants, mechanisms leading to shedding of virus in breast milk and genital tract of adults, treatment of drug-resistant virus in children and adults, and understanding mechanisms leading to the persistence of HIV infection.
Learn More


James Mullins, PhD

James Mullins, PhD

James Mullins, PhD, is a professor of global health, microbiology and medicine, and adjunct professor of laboratory medicine, at the University of Washington. He applies molecular, computational, and virus biology techniques to provide insights into the relationship between HIV and its human hosts in an effort to fight the AIDS pandemic.
Learn More


Andres Finzi, PhD

Andres Finzi, PhD

Andres Finzi, PhD, is director of the Laboratory of Retroviral Entry at the Centre de Recherche du CHUM, University of Montreal, and an adjunct professor of microbiology and immunology at McGill University. He investigates key structural elements within HIV-1 envelope glycoproteins essential for viral entry.
Learn More


Mark Cameron, PhD

Mark Cameron, PhD

Mark Cameron, PhD, is an assistant professor in the Department of Population and Quantitative Health Studies at Case Western Reserve University. He studies the role of interferon signaling genes and the inflammasome in regulating innate and adaptive immune responses.
Learn More


Cheryl Ainslie-Cameron, PhD

Cheryl Ainslie-Cameron, PhD

Title: Instructor at Case Western Reserve University

Cheryl Ainslie-Cameron, PhD, is an instructor at Case Western Reserve University. Her research interests involve the virus:host response interface during acute or chronic illness, as well as the relevant immunotherapeutics or vaccines.
Learn More


Peter Hunt, MD

Peter Hunt, MD

Peter Hunt, MD, is an associate professor of medicine in the Division of Experimental Medicine (DEM) at the University of California San Francisco. His primary research focus is on the inflammatory consequences of HIV infection. He seeks to understand the determinants of persistent immune activation in the presence and the absence of antiretroviral therapy, and assess the impact of immune activation on clinical outcomes.
Learn More


Susan Lynch, PhD

Susan Lynch, PhD

Sue Lynch, PhD, is director of the Colitis and Crohn's Disease Microbiome Research Core, and an associate professor in the Department of Medicine - Gastroenterolgy, at the University of California San Francisco. Her research focuses on microbial communities associated with chronic inflammatory diseases of the gastrointestinal and respiratory tracts, and examines relationships between microbial community composition and function to better understand microbial-host interplay.
Learn More


Kevin Robertson, PhD

Kevin Robertson, PhD

Kevin Robertson, PhD, is a professor of neurology, and the Director of Neuropsychology in the AIDS Neurological Center at the University of North Carolina Chapel Hill. His research interests include HIV-related neurological disease, international HIV research and AIDS clinical trials. 
Learn More


Serena Spudich, MD, MA

Serena Spudich, MD, MA

Serena Spudich, MD, MA, is a professor of neurology, the division chief of Neurological Infections and Global Neurology, and co-director of the Center for Neuroepidemiology and Clinical Neurological Research at the Yale School of Medicine. Her research seeks to understand and address the mechanisms underlying damage to the central nervous system in HIV infection, and the establishment and reduction of viral reservoirs in the central nervous system.
Learn More


Steven Elledge, PhD

Steven Elledge, PhD

Stephen Elledge, PhD, is the Gregor Mendel Professor of Genetics in the Department of Genetics at Harvard Medical School, and the Division of Genetics at Brigham and Women's Hospital. His research is focused on the genetic and molecular mechanisms of eukaryotic response to DNA damage.
Learn More


Jeffrey Milush, PhD / Immunology Core Lab, UCSF

Jeffrey Milush, PhD / Immunology Core Lab, UCSF

Jeffrey Milush, PhD, is an associate professor of medicine, and director of the Core Immunology Laboratory and Flow Cytometry Core at the University of California San Francisco. The UCSF provides sophisticated immunology assays, and expert consultation and educational opportunities to the HIV research community. The core also develops specialized immunology research tools, and initiates and stimulates innovative research projects that address emerging questions in HIV research.
Learn More


Joseph Babigumira

Joseph Babigumira

Joseph Babigumira is an associate professor of Global Health and adjunct associate professor of pharmacy at the University of Washington. His main research interest is improving access to safe and cost-effective diagnostic technologies, medicines, and healthcare delivery platforms in low-income countries. He is involved in the development of methods for applied health economic evaluations specific to poor country settings. His areas of current study are male circumcision for HIV prevention, medicines regulation and quality assurance, alcohol use disorder, breast cancer treatment, and cervical cancer prevention.
Learn More

Blythe Adamson, PhD, MPH

Blythe Adamson, PhD, MPH

Blythe Adamson is a heath economist, data scientist, and pharmacoepidemiologist aiming to identify valuable biomedical innovation for research and development. By creating mathematical models of disease transmission and progression, she compares the costs and benefits of biomedical interventions to prioritize investment portfolios and inform efficient use of scarce health care sector resources. Her personal passion is the development of a safe and effective HIV vaccine.
Learn More



Dobromir Dimitrov, PhD

Dobromir Dimitrov, PhD

Dobromir Dimitrov, PhD, is a senior staff scientist in the Vaccine and Infectious Disease and Public Health Sciences Divisions at the Fred Hutchinson Cancer Research Center, and affiliate assistant professor of applied mathematics at the University of Washington. His research focuses on mathematical modeling of infectious diseases, evaluating impact of interventions for HIV prevention, mathematical biology and dynamical systems. 
Learn More


Michael Boeckh, MD, PhD

Michael Boeckh, MD, PhD

Micahel Boeckh, MD, PhD, is a member of the Vaccine and Infectious Disease and Clinical Research Divisions, and Head of the Infectious Disease Sciences Program, at the Fred Hutchinson Cancer Research Center. He is also a professor of medicine at the University of Washington, and attending physician and head of the SCCA Infectious Disease Consulting Service at the Seattle Cancer Care Alliance. His research focuses on infections in the immunocompromised host, including investigating disease manifestations, risk factors and outcomes. 
Learn More


Florian Hladik, MD, PhD

Florian Hladik, MD, PhD

Florian Hladik, MD, PhD, is a member of the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Research Center. He is also a research professor of obstetrics and gynecology, and adjunct research professor of medicine, at the University of Washington. He uses laboratory studies and systems biology tools to understand the interplay between pathogens, the mucosa, and medical interventions. His research aims to improve the prevention and treatment of sexually transmitted diseases, especially HIV.
Learn More


Joshua Herbeck, PhD

Joshua Herbeck, PhD

Joshua Herbeck, PhD, is an assistant professor of Global Health at the University of Washington. He is is an infectious disease epidemiologist who uses genetic analysis and mathematical modeling to answer questions about pathogen transmission and evolution.
Learn More


Frederick Altice, MD

Frederick Altice, MD

Frederick Altice, MD, is a professor of medicine, epidemiology and public health, and is a clinician, clinical epidemiologist, intervention and implementation science researcher at Yale University School of Medicine and School of Public Health. His primary research project focuses on the interface between infectious diseases and substance use disorders, and he has a special interest in global health.
Learn More